symposia
Monday, July 9, 10:00 am – 12:00 pm
S 1: Imaging for Radiation Therapy and Cancer Biology
Chair: John Kurhanewicz UCSF, San Francisco, USA
Albert van der Kogel, University of Nijmegen, The Netherlands
Gloria C. Li, MSKCC, New York, USA
John Kurhanewicz, USCF, San Francisco, USA
Zaver Bhujwalla, Johns Hopkins University, Baltimore USA
S 2: Track structure physics and chemistry
Chairs: Simon M. Plimblott, University of Manchester, Manchester, UK and Gisela Taucher-Scholz, GSI, Darmstadt, Germany
Benoit Gervais, University of Caen, France.
Simon M. Pimblott, University of Manchester, Manchester, UK
Gisela Taucher-Scholz, GSI, Darmstadt, Germany
Gary Was, University of Michigan, MI, USA
S 3: Triage biological dosimetry after a radiological event
Chairs: Norman Coleman, NCI,National Institutes of Health, Bethesda, USA and Narayani Ramakrishnan, NIAID, NIH,Bethesda, USA
William F. Blakely, Armed Forces Radiobiology Research Institute, Bethesda, USA
Mitsuaki Yoshida, National Institute of Radiological Science, Chiba, Japan
Francois Trompier, IRSN, France
Ruth Wilkins, Consumer and Clinical Radiation Protection Bureau, Ottawa, Canada
S 4: Replication fork management and genome stability: the role of single and double strand break repair
Chair: Simon Powell, Washington University, St. Louis, USA
Conchita Vens, Netherlands Cancer Institute, Amsterdam, The Netherlands
Junran Zhang, Washington University, St. Louis, USA
Eva Petermann, Sussex Centre for Genome Damage and Stability, University of Sussex, Brighton, UK
Kathleen Dixon, University of Arizona, Tucson, USA
S 5: Targeting tumor hypoxia for therapeutic gain
Chairs: Stephanie McKeown, University of Ulster, UK, and William Wilson, Auckland Cancer Society Research Centre, Auckland, NZ
Kaye Williams, University of Manchester, UK
Stephanie McKeown, University of Ulster, UK
William Wilson, Auckland Cancer Society Research Centre, Auckland, NZ
Shinae Kizaka-Kondoh, University of Kyoto, Kyoto, Japan
S 6: Chemotherapy enhanced radiation therapy (CERT)
Chairs : Kathy Mason, MDACC, Houston, USA and Lydia Armstrong, Sanofi-Aventis, Great Valley, USA
Luka Milas, MDACC, Houston, USA
Harry Bartelink, Netherlands Cancer Institute, Amsterdam, The Netherlands
Patricia Eifel, MDACC, Houston, USA
Jolyon Hendry, IAEA, Vienna, Austria
Monday, July 9, 2:00 pm – 4:00 pm
S 7: Molecular Image-Guided Radiotherapy
Chair: Vincent G. Gregoire, University of Leuven, Belgium
Karin Haustermans, University of Leuven, Belgium
Tom Guerrero MDACC, Houston, USA
Robert H. Mach Washington University, St. Louis, USA
Vincent G. Gregoire, University of Leuven, Belgium
Sarah Nelson, UCSF, San Francisco, USA
S 8: Oxidative radicals as signaling agents
Chairs: Peter Wardman, Gray Cancer Institute, Northwood, UK, and David Gius, NCI,National Institutes of Health, Bethesda, USA
Georg Bauer, University of Freiburg, Freiburg, Germany
David Gius, NCI,National Institutes of Health, Bethesda, USA
Masami Watanabe, University of Kyoto, Kyoto, Japan
Diana Averill, University of Quebec, Montreal, Canada
S 9: Radiation and the human environment
Chairs: Maria Luisa Botelho Soares Nuclear &Technical Institute, Portugal, and William Cooper, UC Irvine, Irvine, USA
Stephen Mezyk, California State University at Long Beach, USA
Julie Peller, Indiana University Northwest, Gary, USA
William Cooper, UC Irvine, Irvine, USA
S 10: Protein structures meet DNA damages
Chair: Susan S. Wallace, University of Vermont, USA
Bertrand Castaing, Centre de Biophysique Moléculaire CNRS, France
Silvie Doublie, University of Vermont, USA
Wei Yang, NIDDK, National Institutes of Health, Bethesda, USA
Stephen Kowalczykowski, University of California, Davis, USA
S 11: The Impact of Oncogenes and Translational Control on Tumor Growth Chairs: Brad Wouters University of Maastricht, The Netherlands, and Costas Koumenis, University of Pennsylvania, Philadelphia, USA
Albert Koong, Stanford University, USA
Marianne Koritzinsky, University of Maastricht, The Netherlands
Costas Koumenis, University of Pennsylvania, Philadelphia, USA
Robert Schneider, New York University, NY, USA
S 12: Traditional Chinese Medicine Combined with Conventional Cancer Therapy
Chair: Zhongxing Liao, MDACC, Houston, USA
Lorenzo Cohen, MDACC, Houston, USA
Luming Liu, Fudan University, Shanghai, China
Zhongxing Liao, MDACC, Houston, USA
Yufei Yang, China Academy of Traditional Chinese Medicine, Beijing, China.
Tuesday, July 10, 10:00 am – 12:00 pm
S 13: Structural aspects of radiation-induced DNA damage and repair
Chair: Melanie Spotheim-Maurizot, Centre de Biophysique Moléculaire CNRS, France
Marie Davidkova, Nuclear Physics Institute, Prague, Czech Republic
Francesca Ballarini National Institute of Nuclear Physics, Pavia, Italy
Roman Osman, Mount Sinai School of Medicine, New York, USA
Melanie Spotheim-Maurizot, Centre de Biophysique Moléculaire CNRS, France
S 14: Heavy ion radiobiology in therapy and space
Chair: Yoshiya Furusawa, National Institute of Radiological Sciences, Chiba, Japan.
Irena Gudowska, Karolinska Institute and Stockholm University, Stockholm, Sweden
Guenther Dietze, Physikalisch-Technische Bundesanstalt, Braunschweig, Germany
Eleanor Blakely, Lawrence Berkeley National Lab, Berkeley, USA
Greg Nelson, Loma Linda University Loma Linda, USA
S 15: New data for cancer risk assessment
Chair: Elaine Ron, NCI, NIH, Bethesda, USA
Kiyohiko Mabuchi, RERF, Hiroshima, Japan
Elaine Ron, NCI, NIH, Bethesda, USA
Mary Schubauer-Berigan, CDC, USA
Amy Berrington de Gonzalez, John Hopkins, MD
S 16: Molecular targets for radiosensitization
Chair: Gillies McKenna, University of Oxford, Oxford, UK
Ben Moeller, MDACC, Houston, USA
Thomas Helleday, University of Oxford, Oxford, UK
Brad Wouters, University of Maastricht, Maastricht, The Netherlands
Anjali Gupta, University of Pennsylvania, Philadelphia, USA
S 17: New Directions in Hyperthermia
Chair: Ellen Jones, Duke University, Durham, USA
Elizabeth Repasky, Roswell Park Cancer Institute, Buffalo, USA
Peter Wust, Charite Universitatsmedizin Berlin, Berlin, Germany
David Needham, Duke University, Durham, USA
Rolf Issels, University of Munich, Munich, Germany
S 18: Studies of In Utero Radiation Effects
Chairs: Jack Schull, The Schull Institute, Houston, USA, and Roy Shore
Dale Preston, Hirosoft Inc., CA, USA
Nori Nakamura, RERF, Hiroshima, Japan
Ohtsura Niwa, Kyoto University, Kyoto, Japan
Louis de Saint-Georges, SCK/CEN, Belgium
Tuesday, July 10, 2:00 pm – 4:00 pm
S 19: Current topics in protein damage
Chair: Christian Schoneich, U of Kansas, USA
Michael Davies, University of Sydney, Australia
Chantal Houee-Levin, University Paris Sud, Orsay, France
Ignace Hanssens, Katholieke Universiteit Kortrijk, Belgium
Christian Schoneich, U of Kansas, USA
S 20: Cardiovascular late effects of radiation
Chair: Kei Nakachi, RERF, Hiroshima, Japan
Kazunori Kodama, RERF, Hiroshima, Japan
Steven Lipshultz, University of Miami, Miami, USA
Fiona Stewart, Netherlands Cancer Institute, Amsterdam, The Netherlands
Sarah Darby, CRUK/MRC/BHF Clinical Trial Service Unit and Epidemiological Studies Unit, The Radcliffe Infirmary, Oxford, UK
S 21: How to translate molecular targeting into radiotherapy
Chairs: Michael Baumann, University of Technology Dresden, Dresden, Germany, and Daphne Haas-Kogan, University of San
Francisco, San Francisco, USA
Daphne Haas-Kogan, University of San
Francisco, San Francisco, USA
Paul Harari, University of Wisconsin, Madison, USA
Michael Baumann, University of Technology Dresden, Dresden, Germany
Jean Bourhis, Institut Gustave Roussy, France
S 22: Low dose hypersensitivity: Mechanisms and clinical applications
Chairs : Michael Joiner, Wayne State University, Detroit, USA and Kaushala Prasad Mishra, Bhabha Atomic Research Centre, Trombay, India
Mike Weinfeld, Cross Cancer Institute, Edmonton, Canada
Mansoor Ahmed, Geisinger Clinic, Danville, USA;
Brian Marples, Beaumont Hospital, Troy, USA
Mohindra Pranshu, Tata Memorial Hospital, Mumbai, India
Wednesday, July 11, 10:00 am – 12:00 pm
S 23: Genome wide approaches to predicting DNA damage response from yeast to man
Chairs: Martin Brown, Stanford University, USA and Noelle Metting, DOE Office of Biological and Environmental Research, Washington, USA
James Brown, Stanford University, USA
Marcel Tijsterman, Center for Biomedical Genetics, Utrecht, The Netherlands
Paul Spellman, LBNL, Berkeley, USA
S 24: Radiation damage and electron transfer in nano-materials
Chair: John Miller, Brookhaven National Laboratory, Upton, USA
Jing Peng, Peking University, Beijing, China
Robert Anderson, University of Auckland, Auckland, NZ
Jacqueline Belloni, Université Paris-Sud, Orsay, France
Dan Meisel, University of Notre Dame; Notre Dame, USA
S 25: Pathways impacting radiation-induced cell death
Chairs : Michael Freeman, Vanderbilt University, Nashville, USA and Y-M Park, Roswell Park Cancer Institute, Buffalo, USA
Kathy Held, Massachusetts General Hospital, Boston, USA
Y-M Park, Roswell Park Cancer Institute, Buffalo, USA
Kevin Prise, Queen’s University, Belfast, UK
Yun-Sil Lee, Korea Institute of Radiological & Medical Sciences, Seoul, Korea
S 26: RRS Presidential Symposium: The tumor microenvironment, immunity, and radiation
Chair: William McBride, UCLA, Los Angeles, USA
Theresa Whiteside, University of Pittsburg, Pittsburg, USA
Sandra Demaria, New York University, New York, USA
Edith Lord, University of Rochester, Rochester, USA
William McBride, UCLA, Los Angeles, USA
S 27: Approaching the Holy Grail: Predicting normal tissue sensitivity.
Chair: Lester Peters, Peter Mac Cancer Institute, Melbourne, Australia
Michael McKay, Peter Mac Cancer Institute, Melbourne, Australia.
Christian Andreassen, Aarhus University Hospital, Aahus, Denmark .
Tobias Holscher, University of Technology Carl Gustav Carus, Dresden, Germany
Takashi Imai, NIRS, Japan
S 28: Normal Tissue Cells and Regenerative Medicine
Chair: John R. Fike, UCSF, San Francisco, USA
George Georges, Fred Hutchinson Cancer Research Center, Seattle, USA
John Fike UCSF, San Francisco, USA
Michelle Martin CEA, Service de Génomique Fonctionnelle, Evry, France
Joel Greenberger, University of Pittsburg, Pittsburg, USA
Wednesday, July 11, 2:00 pm – 4:00 pm
S 29: Charged particle microbeam facilities for low dose and low dose rate investigations
Chairs : Silvia Gerardi, INFN - Laboratori Nazionali di Legnaro, Padova, Italy, and Melvyn Folkard, Gray Cancer Institute, Northwood, UK
Marianne Sowa, Pacific Northwest National Lab., USA
Melvyn Folkard, Gray Cancer Institute, Northwood, UK
Alan Bigelow Columbia University, NY, USA
Silvia Gerardi, INFN - Laboratori Nazionali di Legnaro, Padova, Italy
S 30: Industry/academic collaborations: The ins and outs
Chairs: Robert Sutherland, Varian Biosynergy, Mountain View, USA and Robert Radinsky, Amgen, Thousand Oaks, USA
Ken Porter, Technology Transfer Office, University of Colorado, Boulder, USA
Richard Morse, Varian Medical Systems, Mountain View, USA
Dai Chaplin, Oxigene, Oxford, UK
Ernest Hawk, NCI, NIH, Bethesda, USA
S 31: Cutting edge mitigation treatments
Chairs: Jacqueline Williams, University of Rochester, USA and Chris Kalman, Astley Ainslie Hospital, Edinburgh, UK
Shigenobu Nagataki, RERF, Hiroshima, Japan
Jacqueline Williams, University of Rochester, USA
Jennifer Lemon McMaster University, Hamilton, Canada
Viktor Meineke, Federal Armed Forces Medical Academy. Munich, Germany
Patrick Gourmelon, Institut de Radioprotection et de Sûreté Nucléaire, Fontenay aux roses, France
S 32: Space Radiation: What do we know and what do we need to know.
Chairs: Francis Cucinotta, NASA, Johnson Space Center. Houston, USA, and Amy Kronenberg, Lawrence Berkeley National Lab, Berkeley, USA
Mike Sevilla, Oakland University, Rochester, MI, USA
Antonella Tabocchini, Istituto Superiore di Sanita, Rome, Italy
Amy Kronenberg, Lawrence Berkeley National Lab., Berkeley, USA
Charlie Limoli, UC Irvine, Irvine, USA
Thursday, July 12, 10:00 am – 12:00 pm
S 33: Adaptive Response Induction by Low dose and Low Dose Rate
Chair: Ron Mitchel, Atomic Energy of Canada Limited. Chalk River, Canada
Andrew Wyrobek, Lawrence Berkeley National Lab., Berkeley, USA
Kazuo Sakai, Central Research Institute of Electric Power Industry, Japan
Brenda Rodgers, Texas Tech University, Lubbock, USA
Pam Sykes, Flinders University of South Australia, Australia
S 34: Reaction pathways leading to DNA damage
Chair: Thierry Douki, SCIB/DRFMC, CEA/Grenoble, France
Marc M. Greenberg, John Hopkins University, Baltimore, USA
Pavel Lobachevsky, Peter Mac Cancer Centre, Melbourne, Australia
Yelena Margolin, MIT, Boston, USA
Thierry Douki, SCIB/DRFMC, CEA/Grenoble, France
S 35: Radiation biology, chemistry and physics of nuclear power
Chairs: Yousuke Katsumura, University of Tokyo, Tokyo, Japan, Dorota Swiatla-Wojcik, Institute of Applied Radiation Chemistry, Technical University, Lodz, Poland, and Xu Su, Chinese Center for Medical Response to Radiation Emergency Beijing, China
Carol Burns, Los Alamos National Lab., Los Alamos, USA
Catherine Corbel, CEA-Saclay, DSM/DRECAM/SCM, Gif-sur-Yvette, France
Colin English, Nexia Solutions Ltd. Sellafield, UK
Yosuke Katsumura, University of Tokyo, Tokyo, Japan
S 36: Mechanisms of radiation induced bowel damage and possible intervention strategies
Chairs: Fiona Stewart, Nethelands Cancer Institute, Amsterdam, The Netherlands,and Marie Catherine Vozenin-Brotons, Institut Gustave Roussy, Villejuif, France ;
Meritxell Molla, University of Barcelona, Barcelona, Spain.
Jacqueline Kruse, Nethelands Cancer Institute, Amsterdam, The Netherlands.
Marie-Catherine Vozenin-Brotons, Institut Gustave Roussy Villejuif, France.
Martin Hauer-Jensen, University of Arkansas, Little Rock, USA
S 37: Radiation-induced genomic instability
Chairs: Takeo Ohnishi, Nara Medical University, Nara, Japan, and Munira Kadhim, MRC Radiation and Genome Stability Unit, Oxford, UK
Takeo Ohnishi, Nara Medical University, Nara, Japan,
William Morgan, University of Maryland, Baltimore, USA.
Frederick Alt, Harvard University, Cambridge, USA
P. Uma Devi, Kasturba Medical College, Manipal, India
S 38: Tumor Metabolism and Metastases
Chairs: Ian Stratford, University of Manchester, UK, and Amato Giaccia, Stanford University, USA
Richard Hill, University of Toronto, Toronto, Canada
Janine Erler, Stanford University, USA
Ian Stratford, University of Manchester, UK
Zhong Yun, Yale University, New Haven, USA
Thursday, July 12, 2:00 pm – 4:00 pm
S 39: Cancer Stem Cells
Chair: Michael Clarke, Stanford University, USA
Frank Pajonk, UCLA, Los Angeles, USA
Ricardo Fodde, Erasmus University Medical Center, Netherlands
Michael Clarke, Stanford University, USA
S 40: The relationship between checkpoint signaling and DNA repair
Chair: Ted DeWeese, Johns Hopkins University, Baltimore, USA
Phang-Lang Chen, UC Irvine, Irvine, USA
Sang Eun Lee, University of Texas, San Antonio, USA
Esther Hammond, Stanford University, USA
David Toczyski, UCSF, San Francisco, USA
S 41: Clustered and tandem DNA lesions
Chairs: Peter O’Neill, MRC Radiation and Genome Stability Unit, Oxford, UK and Naoya Shikazono, Japan Atomic Energy Research Institute, Takasaki, Japan
Lynn Harrison, Louisiana State University Health Sciences Center,
Shreveport, USA
Peter O’Neill, MRC Radiation and Genome Stability Unit, Oxford, UK
Jean Luc Ravanat, SCIB/DRFMC, CEA/Grenoble, France
Betsy Sutherland, Brookhaven National Laboratory Upton, NY, USA
S 42: Radiation and polymers
Chairs: Seiichi Tagawa, University of Osaka, Osaka, Japan and Alison M. Funston, University of Melbourne, Melbourne, Australia
Sina Burkert, Leibniz Institute of Polymer Research Dresden, Germany
Shu Seki, University of Osaka, Osaka, Japan,
Seiicchi Tagawa, University of Osaka, Osaka, Japan,
Piotr Ulanski, Technical University of Lodz, Lodz, Poland
S 43: Influence of the tumor vasculature on response to therapy
Chairs: Adriana Haimovitz-Friedman, MSKCC, New York, USA, and Donald McDonald, UCSF, San Francisco, USA
Martin Pruschy, University Hospital Zurich, Zurich, Switzerland
Emile Voest, University Medical Center Utrecht, Utrecht, The Netherlands
Donald McDonald, UCSF, San Francisco, USA
Adriana Haimovitz-Friedman, MSKCC, New York, USA,
|
